Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review
At the end of 2019 a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China …
CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China …
Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS
The role of non-invasive respiratory support (high-flow nasal oxygen and noninvasive
ventilation) in the management of acute hypoxemic respiratory failure and acute respiratory …
ventilation) in the management of acute hypoxemic respiratory failure and acute respiratory …
ESICM guidelines on acute respiratory distress syndrome: definition, phenoty** and respiratory support strategies
The aim of these guidelines is to update the 2017 clinical practice guideline (CPG) of the
European Society of Intensive Care Medicine (ESICM). The scope of this CPG is limited to …
European Society of Intensive Care Medicine (ESICM). The scope of this CPG is limited to …
[PDF][PDF] Living guidance for clinical management of COVID-19: living guidance, 23 November 2021
World Health Organization - 2021 - apps.who.int
This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …
Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic …
Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …
[PDF][PDF] COVID-19 clinical management: living guidance, 25 January 2021
( 2021 World Health Organization - 2021 - apps.who.int
The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …
[PDF][PDF] Clinical management of COVID-19: interim guidance, 27 May 2020
(2020 World Health Organization - 2020 - apps.who.int
Methods The original version of this document was developed in consultation with the
International Forum for Acute Care Trialists (InFACT), International Severe Acute Respiratory …
International Forum for Acute Care Trialists (InFACT), International Severe Acute Respiratory …
An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal
Over 200 years ago, René Laennec published the first description of emphysema, an
important pathobiological element of what is today known as chronic obstructive pulmonary …
important pathobiological element of what is today known as chronic obstructive pulmonary …
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Background The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …
the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting …
ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure
Background High-flow nasal cannula (HFNC) has become a frequently used noninvasive
form of respiratory support in acute settings; however, evidence supporting its use has only …
form of respiratory support in acute settings; however, evidence supporting its use has only …